1.
the project was launched on June 1st 2013 and will last 27 months
Comment: I am happy about this work but not for
mycobacteriophage choice.The same phages are used in all works with mycobacteria (the host range for D29 is very large and includes both slow and fast-growing species). This aspect ( this is my opinion) is not a favourable point for phage therapy in Buruli:
we must wait until a specific phage for Mycobacterium ulcerans strain is isolated together in the same country.
This work supports the timeliness of phage therapy before the infection to become chronic (
33 days) and confirms my working hypothesis:
a,
b,
c
